HolderBook

CLEARSIDE BIOMEDICAL INC (CLSD)

Institutional ownership reported to the SEC as of Q3 2025, across 28 quarters.

3
Reporting holders
$446.9K
Reported value
0.0%
Held as options
-37
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
Carmignac Gestion$399.2K100,5560.01%23q-93.3%-$5.6M
Apollon Wealth Management, LLC$46.8K11,7930.00%newNEW
OSAIC HOLDINGS, INC.$9002,5000.00%23q-7.6%

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 20253$446.9K114,8491020.0%
Q2 202540$7.0M8,786,8935660.0%
Q1 202541$7.9M8,543,93134141.1%
Q4 202441$8.9M9,371,44351180.4%
Q3 202446$12.9M10,036,680108121.0%
Q2 202445$17.8M13,711,420511130.1%
Q1 202448$23.3M15,206,622161330.2%
Q4 202340$8.8M7,427,3727860.7%
Q3 202340$6.6M7,484,17167101.6%
Q2 202346$9.3M8,126,747610101.8%
Q1 202343$8.5M7,999,87968121.9%
Q4 202242$8.3M7,348,99094101.2%
Q3 202253$13.9M12,079,57964211.8%
Q2 202252$20.5M13,705,09867241.9%
Q1 202258$38.1M16,371,849913191.5%
Q4 202165$63.4M21,285,770152397.7%
Q3 202168$126.9M20,253,818222294.2%
Q2 202153$98.3M19,662,301813152.6%
Q1 202154$44.5M17,736,516181861.6%
Q4 202041$39.2M14,286,0805890.2%
Q3 202041$18.5M11,974,11151190.1%
Q2 202044$22.5M11,782,473101191.4%
Q1 202042$20.3M11,537,162712103.4%
Q4 201946$24.3M8,219,96915691.9%
Q3 201932$4.4M6,992,7866280.0%
Q2 201946$4.4M4,518,721106160.3%
Q1 201957$8.5M6,132,498710190.0%
Q4 201869$14.1M13,089,7633210.5%